Significance of PD-L1 expressing tumor cells in the combined positive score with triple negative breast cancer

被引：0
|
作者：
Evans, Tiffany [1 ]
Hund, Stephanie [1 ]
Krohn, Darlene [1 ]
Emancipator, Kenneth [2 ]
Juco, Jonathon [2 ]
Portier, Bryce [1 ]
Tabuena-Frolli, Siena [1 ]
Kulangara, Karina [1 ]
机构：
[1] Agilent, Carpinteria, CA USA
[2] Merck Sharp & Dohme Corp, Kenilworth, NJ USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS4-15
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Macrophages are important source of PD-L1 and PD-L1 expressing in macrophages affect the prognosis of NSCLC patients with tumor PD-L1 negative
    Liu, Y.
    Cao, L.
    Che, X.
    Qiu, X.
    Li, Z.
    Yang, B.
    Wang, S.
    Qu, X.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 531 - 532
  • [42] PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey
    Cerbelli, Bruna
    Cirillo, Alessio
    Pomati, Giulia
    Pernazza, Angelina
    Ascione, Andrea
    Pisegna, Simona
    Pisano, Annalinda
    Leopizzi, Martina
    Pignataro, Maria Gemma
    Costarelli, Leopoldo
    Mule, Antonino
    Vecchione, Andrea
    Catalano, Piera
    Coppola, Luigi
    Perrone, Giuseppe
    Perracchio, Letizia
    Anemona, Lucia
    Mastracchio, Antonio
    Nardi, Stefano
    Reitano, Renato
    Massari, Annalisa
    Grillo, Lucia Rosalba
    Liberati, Fabrizio
    Della Rocca, Carlo
    Marchetti, Paolo
    Botticelli, Andrea
    D'Amati, Giulia
    TUMORI JOURNAL, 2024, 110 (01): : 44 - 48
  • [43] Nuclear transportation of PD-L1 accelerates Triple-negative breast cancer metastasis
    Gohara, Yuma
    Tomonobu, Nahoko
    Kinoshita, Rie
    Yamamoto, Kenichi
    Murata, Hitoshi
    Sakaguchi, Masakiyo
    CANCER SCIENCE, 2025, 116 : 1819 - 1819
  • [44] PD-L1 Gene Amplification in Triple-negative Breast Cancer: Implications for Immunotherapy
    Peng, K. X.
    Anderson, K. S.
    McCullough, A. E.
    Reddy, S. K.
    Basu, G. D.
    Northfelt, D. W.
    Andreozzi, M.
    Barrett, M. T.
    Pockaj, B. A.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S70 - S70
  • [45] Ferroptosis Inducers Upregulate PD-L1 in Recurrent Triple-Negative Breast Cancer
    Desterke, Christophe
    Xiang, Yao
    Elhage, Rima
    Duruel, Clemence
    Chang, Yunhua
    Hamai, Ahmed
    CANCERS, 2024, 16 (01)
  • [46] PD-L1 expression in triple negative breast cancer (TNBC) is associated with improved outcomes
    Mardones, M. A.
    Grosser, D.
    Levin, M. K.
    Daoud, Y.
    Palucka, K.
    O'Shaughnessy, J.
    Osborne, C.
    CANCER RESEARCH, 2017, 77
  • [47] Future of PD-1/PD-L1 axis modulation for the treatment of triple-negative breast cancer
    Nakhjavani, Maryam
    Shigdar, Sarah
    PHARMACOLOGICAL RESEARCH, 2022, 175
  • [48] Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
    Yoshikawa, Katsuhiro
    Ishida, Mitsuaki
    Yanai, Hirotsugu
    Tsuta, Koji
    Sekimoto, Mitsugu
    Sugie, Tomoharu
    BMC CANCER, 2021, 21 (01)
  • [49] The immune checkpoint PD-L1 alters choline kinase expression and metabolism in triple negative breast cancer cells
    Pacheco-Torres, Jesus
    Penet, Marie-France
    Wildes, Flonne
    Mironchik, Yelena
    Krishnamachary, Balaji
    Bhujwalla, Zaver M.
    CANCER RESEARCH, 2020, 80 (16)
  • [50] Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
    Katsuhiro Yoshikawa
    Mitsuaki Ishida
    Hirotsugu Yanai
    Koji Tsuta
    Mitsugu Sekimoto
    Tomoharu Sugie
    BMC Cancer, 21
12345